GAMMA Investing LLC Has $109,000 Stake in Select Medical Holdings Corporation (NYSE:SEM)

GAMMA Investing LLC lifted its position in shares of Select Medical Holdings Corporation (NYSE:SEM) by 217.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,501 shares of the health services provider’s stock after acquiring an additional 4,453 shares during the quarter. GAMMA Investing LLC’s holdings in Select Medical were worth $109,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. American Century Companies Inc. boosted its holdings in shares of Select Medical by 1,309.5% during the 4th quarter. American Century Companies Inc. now owns 137,169 shares of the health services provider’s stock valued at $2,586,000 after acquiring an additional 127,437 shares in the last quarter. Sterling Capital Management LLC lifted its holdings in Select Medical by 9.5% during the 4th quarter. Sterling Capital Management LLC now owns 11,304 shares of the health services provider’s stock worth $213,000 after buying an additional 978 shares during the period. Vanguard Group Inc. lifted its holdings in Select Medical by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider’s stock worth $239,640,000 after buying an additional 131,228 shares during the period. Deutsche Bank AG lifted its holdings in Select Medical by 47.4% during the 4th quarter. Deutsche Bank AG now owns 93,316 shares of the health services provider’s stock worth $1,759,000 after buying an additional 30,023 shares during the period. Finally, Swiss National Bank lifted its holdings in Select Medical by 0.7% during the 4th quarter. Swiss National Bank now owns 217,400 shares of the health services provider’s stock worth $4,098,000 after buying an additional 1,500 shares during the period. Institutional investors and hedge funds own 89.48% of the company’s stock.

Insider Buying and Selling

In other Select Medical news, Director Parvinderjit S. Khanuja bought 21,000 shares of the business’s stock in a transaction dated Monday, May 5th. The shares were purchased at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the purchase, the director directly owned 65,089 shares of the company’s stock, valued at approximately $977,636.78. This represents a 47.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David S. Chernow sold 225,000 shares of the business’s stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the transaction, the chief executive officer owned 714,516 shares in the company, valued at $12,861,288. The trade was a 23.95% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.60% of the company’s stock.

Wall Street Analyst Weigh In

SEM has been the topic of several recent research reports. Mizuho initiated coverage on Select Medical in a report on Wednesday, April 16th. They set an “outperform” rating and a $25.00 target price on the stock. Royal Bank Of Canada cut their target price on Select Medical from $23.00 to $19.00 and set an “outperform” rating on the stock in a report on Wednesday, May 7th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Select Medical currently has a consensus rating of “Moderate Buy” and a consensus price target of $26.00.

Select Medical Stock Performance

Shares of Select Medical stock opened at $15.28 on Monday. Select Medical Holdings Corporation has a one year low of $14.03 and a one year high of $40.98. The firm has a market capitalization of $1.96 billion, a price-to-earnings ratio of 11.40, a PEG ratio of 0.80 and a beta of 1.32. The business has a 50-day simple moving average of $15.28 and a 200 day simple moving average of $17.06. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.16 and a quick ratio of 1.16.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.01). The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The business’s quarterly revenue was down 24.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.75 earnings per share. On average, research analysts anticipate that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical declared that its Board of Directors has authorized a share repurchase program on Thursday, May 1st that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the health services provider to reacquire up to 42.6% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

Select Medical Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were issued a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date was Thursday, May 15th. Select Medical’s dividend payout ratio is currently 18.66%.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.